Skip to content

The association between atrophic gastritis and Helicobacter pylori eradication

The factors that affect the eradication of first-line therapy in atrophic gastritis: A prospective multicenter study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003851
Enrollment
220
Registered
2019-04-25
Start date
2019-05-20
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University, Wonju Severance Christian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Men or women aged 19 to over 80 (2) Atrophic gastritis is seen (a significant range of mucosal pale and sparkling submucosal blood vessels are markedly observed, Kimura classification can be applied), and H. pylori test (CLO) positive (3) Patients who agreed to the study (4) Patients who desire H. pylori eradication

Exclusion criteria

Exclusion criteria: (1) H. pylori test (CLO) negative (2) Severe systemic or coagulopathic disorders (3) previously treated for H. pylori eradication (4) If there is a previous history of antibiotic treatment before 4 weeks of the start of study (5) Patients with a history of gastrectomy (6) Patients have allergies to antibiotics (7) Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
Identification of risk factors associated with eradication of H. pylori in patients with atrophic gastritis

Secondary

MeasureTime frame
Success rate of H. pylori eradication in atrophic gastritis;Level measurement of Pepsinogen I and II;clarithromycin resistance;Compliance of antibiotics

Countries

Korea, Republic of

Contacts

Public ContactSu Young Kim

Yonsei University, Wonju Severance Christian Hospital

breeze1212@naver.com+82-33-741-1229

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026